Abstract
<p>A new journal has been launched by Barcaray Publishing: Journal of Advanced Therapies and Medical Innovation Sciences (J.ATAMIS, www.j-atamis.org). This journal fills a crucial gap in the literature – and in the cycle of advances in medical science, therapeutics and devices - covering the pipeline from idea through proof of concept studies and start-up funding to regulatory approval. It will be multi-disciplinary and unusually we will have significant input from funders - both angel and venture capital-, start-up CEO’s, and regulators as well as medical scientists and triallists. We have quite frankly a stellar editorial board, with leading lights of biotechnology, medical devices, new and established pharma as well as the “other side”, CEO’s and investors. </p>
Highlights
A new journal has been launched by Barcaray Publishing: Journal of Advanced Therapies and Medical Innovation Sciences (J.ATAMIS, www.j-atamis.org)
This journal fills a crucial gap in the literature – and in the cycle of advances in medical science, therapeutics and devices - covering the pipeline from idea through proof of concept studies and start-up funding to regulatory approval
I (AJSC) am proud to have been chosen as its first editor-in-chief. This journal fills a crucial gap in the literature – and in the cycle of advances in medical science, therapeutics and devices - covering the pipeline from idea through proof of concept studies and startup funding to regulatory approval
Summary
A new journal has been launched by Barcaray Publishing: Journal of Advanced Therapies and Medical Innovation Sciences (J.ATAMIS, www.j-atamis.org). Corresponding author: Professor Andrew J Stewart Coats, Vice President Monash University Australia and University of Warwick UK Email: ajscoats@aol.com
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Journal of Advanced Therapies and Medical Innovation Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.